Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Schuck

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
AJR. American Journal of Roentgenology|September 1, 1989
MR detection of probable hematopoietic hyperplasia involving the knees, proximal femurs, and pelvisJ E Schuck, D J Czarnecki
Allergy|March 27, 2010
Wheat-dependent exercise-induced anaphylaxis exclusively during menstruationJ Fischer, E Schuck, T Biedermann
The British Journal of Dermatology|September 18, 2008
Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical studyA Gueniche, B Knaudt, E Schuck, et al.
The British Journal of Dermatology|June 20, 2018
Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switchesA Blauvelt, J-P Lacour, J F Fowler, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
AJR. American Journal of Roentgenology|September 1, 1989
MR detection of probable hematopoietic hyperplasia involving the knees, proximal femurs, and pelvisJ E Schuck, D J Czarnecki
Allergy|March 27, 2010
Wheat-dependent exercise-induced anaphylaxis exclusively during menstruationJ Fischer, E Schuck, T Biedermann
The British Journal of Dermatology|September 18, 2008
Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical studyA Gueniche, B Knaudt, E Schuck, et al.
The British Journal of Dermatology|June 20, 2018
Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switchesA Blauvelt, J-P Lacour, J F Fowler, et al.
Pageof 1